When blood glucose levels increase, beta cells of the pancreas release insulin, which stimulates body cells to take up glucose. As glucose levels fall, insulin secretion decreases. This regulation is an example of:

Core Concept

PILLAR 1 — MOLECULAR/CONCEPTUAL MECHANISM

Step-by-Step Analysis

Glucose homeostasis in vertebrates depends on negative feedback, a regulatory architecture in which the product of a signaling pathway opposes the original stimulus, driving the system back toward a set point. When dietary carbohydrates are absorbed across intestinal epithelium via sodium-glucose cotransporters (SGLT1), blood glucose concentration climbs. Pancreatic β cells detect this rise through the membrane transporter GLUT2, which allows glucose to enter at a rate proportional to extracellular concentration. Intracellular glucose is phosphorylated by glucokinase (the rate-limiting "glucose sensor" enzyme) and catabolized through glycolysis and aerobic respiration, elevating the cytoplasmic ATP:ADP ratio. Increased ATP binding closes ATP-sensitive potassium channels (KATP), depolarizing the plasma membrane. Voltage-gated calcium channels (Cav1.2) open in response, permitting Ca2+ influx down its electrochemical gradient. The resulting surge in cytoplasmic Ca2+ triggers SNARE-mediated exocytosis of insulin-containing secretory granules. Secreted insulin binds receptor tyrosine kinases (IR) on target cells—hepatocytes, adipocytes, skeletal myofibers—activating a phosphorylation cascade through IRS-1, PI3-kinase, and Akt. One downstream effect is translocation of GLUT4 vesicles to the plasma membrane, inserting additional glucose transporters that accelerate cellular glucose uptake. As glucose is cleared from the bloodstream, the stimulus diminishes: less glucose enters β cells, ATP:ADP falls, KATP channels reopen, membrane repolarizes, calcium influx slows, and insulin secretion declines. This self-limiting loop is the molecular signature of negative feedback.

Why Other Options Are Wrong

PILLAR 2 — STEP-BY-STEP LOGIC

The question stimulus explicitly states three sequential facts: (1) rising blood glucose triggers insulin release, (2) insulin stimulates cellular glucose uptake, and (3) falling glucose causes insulin secretion to decrease. The critical reasoning step is recognizing that the final outcome—lower glucose—directly reduces the very signal that initiated the pathway. The response (glucose clearance) counteracts the perturbation (hyperglycemia), restoring the internal milieu near its physiological set point (≈70–110 mg/dL in humans). This directional reversal—output opposes input—is the defining hallmark of negative feedback, distinguishing it from positive feedback, in which the response amplifies the stimulus and accelerates departure from the set point. Because every clause in the stimulus describes a stabilizing, self-dampening cycle, option B (negative feedback) is the only classification consistent with the regulatory logic described.

PILLAR 3 — DISTRACTOR ANALYSIS

Option A (positive feedback) is the most common trap. Students may fixate on the word "stimulates" in the second clause and erroneously conclude that amplification is occurring. Positive feedback, however, requires that the response reinforce and intensify the original stimulus—as in oxytocin-driven uterine contractions during labor or sodium-channel depolarization during an action potential. Here, insulin's effect reduces glucose, which suppresses further insulin release; the loop reverses rather than amplifies, exposing the flaw in choosing A.

Option C (feedforward regulation) attracts students who notice the anticipatory nature of some glucose-regulatory signals (e.g., cephalic-phase insulin release triggered by the sight or smell of food). Feedforward mechanisms act before the perturbation occurs to pre-emptively adjust the system. The stimulus, however, describes a reactive process: insulin is released after glucose has already risen, not in anticipation of a rise. Thus, C mischaracterizes the temporal relationship.

Option D (antagonistic regulation via two opposing hormones) reflects confusion with the broader glucose-homeostasis model, which includes both insulin (hypoglycemic) and glucagon (hyperglycemic) as counterbalancing endocrine signals from pancreatic islets. While this dual-hormone system exists, the question asks only about the insulin pathway's self-regulating behavior—not the relationship between insulin and glucagon. Selecting D therefore imports outside knowledge that is irrelevant to the specific regulatory pattern described.